Woodward Diversified Capital, Llc
Source: SEC Form 13F · as of Mar 2026Woodward Diversified Capital, Llc holds 16 biotech & pharma companies tracked by BioSniper, totaling $21.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$21.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GENELUX Corp (GNLX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GNLXGENELUX Corp | 2,117,183 | $5.9M |
| JNJJOHNSON & JOHNSON | 15,570 | $3.6M |
| AMGNAMGEN INC | 6,189 | $2.2M |
| ABBVAbbVie Inc. | 8,925 | $1.9M |
| MRKMerck & Co., Inc. | 11,635 | $1.4M |
| PMPhilip Morris International Inc | 8,534 | $1.3M |
| PFEPFIZER INC | 31,966 | $881K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,974 | $871K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,719 | $558K |
| ABTABBOTT LABORATORIES | 5,447 | $527K |
| GILDGILEAD SCIENCES, INC. | 3,715 | $511K |
| LLYELI LILLY & Co | 494 | $458K |
| CAHCardinal Health Inc. | 2,109 | $451K |
| BMYBRISTOL MYERS SQUIBB CO | 3,744 | $225K |
| MCKMcKesson Corporation | 249 | $216K |
| OCULOCULAR THERAPEUTIX, INC | 11,200 | $110K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.